About PainDure

About company

Founded in November 2009, Paindure is developing a biodegradable implant-based product enabling minimally invasive localized targeted therapy for treating migraine headaches. Treatment involves administering a long-term (6 months) local anesthetic. Prototype development can be completed within a 12-18 months period. Patents – provisional submitted on March 2009 regarding new use drug combination, new combination of formulation (slow release) and new administration.